Adam Feuerstein: Real Weakness to Inhibitex this AM due to Merrill Analyst Cautious Comments at Investor Meeting

by Allie Wickman, Benzinga Staff Writer
January 4, 2012 11:50 AM | 1 seconds read |
View tweet here.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Analyst ColorNewsIntraday UpdateAnalyst RatingsMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!